GlassScriptPhysician profile
Maureen L Westgarth
NPI 1366609976
$6,573.04
in general payments reported to CMS, 2019-2025
40 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,234 · 2022: $1,266 · 2023: $1,518 · 2024: $1,456 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,963 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,962.67 |
| Education | $109.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $889.63 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $711.45 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $643.92 | 2021-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $438.10 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $343.72 | 2021-2025 | |
| Novo Nordisk INC | $334.84 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $324.12 | 2021-2025 | Verquvo, Capvaxive, Gardasil |
| Astrazeneca Pharmaceuticals LP | $318.01 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Astellas Pharma US INC | $229.06 | 2021-2024 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $214.11 | 2021-2025 | Eliquis, Camzyos |
| Currax Pharmaceuticals LLC | $208.43 | 2022-2025 | Contrave, Onzetra Xsail, Nexletol |
| Amgen INC. | $174.05 | 2021-2025 | Otezla, Repatha, Otezla |
| Exact Sciences Corporation | $171.54 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Mylan Specialty L.P. | $161.65 | 2021-2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $128.62 | 2021-2024 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Westgarth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.